Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07909226

Lactate/Albumin Ratio and Mortality in Respiratory Failure

Conditions: Acute Respiratory Failure, Critical Illness, Mortality, Mortality Prediction

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 1250

Sponsor: Kocaeli City Hospital

Location: Kocaeli City Hospital İzmit Kocaeli

Summary

This retrospective observational study aims to evaluate the association between the lactate-to-albumin ratio (LAR) measured at ICU admission and 28-day mortality in adult patients admitted to the intensive care unit with acute respiratory failure. The study will also compare the prognostic value of LAR with that of existing clinical and laboratory parameters.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older * First ICU admission with a diagnosis of acute respiratory failure between April 2023 and June 2026 Exclusion Criteria: * Missing data in the hospital information system * Known terminal-stage solid organ malignancy * Laboratory data (lactate/albumin) obtained after albumin replacement * ICU stay shorter than 24 hours * Death within the first 24 hours of ICU admission * Pregnancy * Cardiopulmonary resuscitation within 24 hours before ICU admission

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07909226). StuddyBuddy aggregates publicly available trial information.